Literature DB >> 20878300

[Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge].

Frank Weidemann1, Markus Niemann, Claudia Sommer, Meinrad Beer, Frank Breunig, Christoph Wanner.   

Abstract

Fabry's disease is a rare genetic storage disorder leading to an accumulation of globotriaosylceramides in the lysosomes of various organs. Being X-chromosomal-linked, most studies in the past focused on involvement in male patients. However, it has been elucidated recently that female patients can present typical organ involvement and, thus, have to be treated respectively. This synopsis wants to systematically review the typical organ involvement in female Fabry patients. Moreover, therapy recommendations especially for female patients are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878300     DOI: 10.1007/s00063-010-1102-y

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  21 in total

1.  White matter lesion severity in male and female patients with Fabry disease.

Authors:  A Fellgiebel; M J Müller; M Mazanek; K Baron; M Beck; P Stoeter
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 2.  Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.

Authors:  Björn Oqvist; Barry M Brenner; João Paulo Oliveira; Alberto Ortiz; Roland Schaefer; Einar Svarstad; Christoph Wanner; Kate Zhang; David G Warnock
Journal:  Nephrol Dial Transplant       Date:  2009-03-16       Impact factor: 5.992

3.  Autonomic skin responses in females with Fabry disease.

Authors:  Anette T Møller; Flemming W Bach; Ulla Feldt-Rasmussen; Ase K Rasmussen; Lis Hasholt; Claudia Sommer; Steen Kølvraa; Troels Staehelin Jensen
Journal:  J Peripher Nerv Syst       Date:  2009-09       Impact factor: 3.494

4.  Evidence for preferential X-chromosome inactivation in a family with Fabry disease.

Authors:  H H Ropers; T F Wienker; T Grimm; K Schroetter; K Bender
Journal:  Am J Hum Genet       Date:  1977-07       Impact factor: 11.025

5.  Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease.

Authors:  Jaymin S Shah; Derralynn A Hughes; Bhavesh Sachdev; Maite Tome; Deirdre Ward; Philip Lee; Atul B Mehta; Perry M Elliott
Journal:  Am J Cardiol       Date:  2005-09-15       Impact factor: 2.778

6.  Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.

Authors:  M Ries; H J Kim; C K Zalewski; M A Mastroianni; D F Moore; R O Brady; J M Dambrosia; R Schiffmann; C C Brewer
Journal:  Brain       Date:  2006-11-14       Impact factor: 13.501

7.  Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.

Authors:  G Altarescu; G Chicco; C Whybra; S Delgado-Sanchez; N Sharon; M Beck; D Elstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

8.  Nomen est omen. Fabry disease.

Authors:  F Weidemann; C Wanner; F Breunig
Journal:  Eur J Echocardiogr       Date:  2008-05-20

9.  Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.

Authors:  Frank Weidemann; Markus Niemann; Frank Breunig; Sebastian Herrmann; Meinrad Beer; Stefan Störk; Wolfram Voelker; Georg Ertl; Christoph Wanner; Jörg Strotmann
Journal:  Circulation       Date:  2009-01-19       Impact factor: 29.690

10.  Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease.

Authors:  Natalie Jansen Street; Michael S Yi; Laurie A Bailey; Robert J Hopkin
Journal:  Genet Med       Date:  2006-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.